LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 1 | 28.21 | 84.90 | 1229 | 2091 | 0.5876 | 0.7827 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 28.21 | 84.90 | 1292 | 2091 | 0.6177 | 0.8021 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 28.21 | 84.90 | 1327 | 2091 | 0.6345 | 0.8125 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 28.21 | 84.90 | 1409 | 2091 | 0.6737 | 0.8362 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 29.92 | 84.90 | 1314 | 2237 | 0.5872 | 0.7867 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 29.92 | 84.90 | 1366 | 2237 | 0.6104 | 0.8014 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 29.92 | 84.90 | 1258 | 2237 | 0.5622 | 0.7703 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 29.92 | 84.90 | 1300 | 2237 | 0.5810 | 0.7826 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 31.62 | 84.90 | 1267 | 2449 | 0.5172 | 0.7458 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 31.62 | 84.90 | 1319 | 2449 | 0.5384 | 0.7604 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 31.62 | 84.90 | 1323 | 2449 | 0.5401 | 0.7615 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 31.62 | 84.90 | 1358 | 2449 | 0.5544 | 0.7710 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 33.32 | 84.90 | 1285 | 2722 | 0.4720 | 0.7213 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 33.32 | 84.90 | 1340 | 2722 | 0.4922 | 0.7358 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 33.32 | 84.90 | 1348 | 2722 | 0.4952 | 0.7379 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 33.32 | 84.90 | 1382 | 2722 | 0.5076 | 0.7465 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 35.03 | 84.90 | 1355 | 2991 | 0.4530 | 0.7144 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 35.03 | 84.90 | 1405 | 2991 | 0.4697 | 0.7265 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 35.03 | 84.90 | 1294 | 2991 | 0.4326 | 0.6991 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 35.03 | 84.90 | 1314 | 2991 | 0.4393 | 0.7042 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 36.73 | 84.90 | 1354 | 3254 | 0.4161 | 0.6929 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 36.73 | 84.90 | 1389 | 3254 | 0.4268 | 0.7011 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 36.73 | 84.90 | 1374 | 3254 | 0.4222 | 0.6976 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 36.73 | 84.90 | 1394 | 3254 | 0.4284 | 0.7023 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 38.43 | 84.90 | 1333 | 3459 | 0.3853 | 0.6734 | MN20160318_Q02 | I09 |